Head of Research
Ovoca Bio
Dublin 2, Dublin, Ireland
Mikhail Lomonosov, PhD, Head of Research Department in Ovoca Bio Plc, Ireland. Dr Lomonosov completed his undergraduate in biochemistry at Moscow State University and his PhD in Molecular Genetics from the Danish Cancer Society, Copenhagen, and at the Institute of Gene Biology, Moscow. Mikhail continued his postdoctoral studies at ICGEB, Trieste, Italy, and at Cambridge University, UK. For the last 9 years, Dr Lomonosov has led the research and development of Orenetide, a novel CNS active peptide, developed for the treatment of HSDD in women. More recently, Dr Lomonsov has been responsible for manufacturing of the drug product for clinical trials and managing the international patenting of Ovoca's IP.
Disclosure information not submitted.
Wednesday, October 19, 2022
9:00 AM – 9:30 AM ET